Have an Innovative Digital Health Solution? Partner with G4A

G4A Partnerships are a great opportunity to get your solution in front of Bayer executives and decision makers. All the applications will be reviewed by key stakeholders who have global visibility and responsibility. If selected for the challenge(s) you've applied to, you will engage in conversations with Bayer representatives to determine a model of partnership that is mutually beneficial.

Legal entities or persons who are 18 years old or older may apply for our G4A initiatives. Please only apply to challenge areas that you believe your solution solves. 2019 Challenges areas are:

  • Cardiovascular
  • Dermatology
  • Digital Therapeutics
  • Global Health
  • Neurotechnology
  • Oncology
  • Ophthalmology
  • Pulmonology
  • Radiology
  • Women's Health
  • Voice-Tech

G4A applications are reviewed on a weekly basis, stand-out and submit early, the deadline is May 31 2019 12:00 PM (CEST).

Applications will be open for you to submit your solution to the G4A SurveyMonkey Apply platform. You will need to fill out an online form in which you will be able to provide information about your solution, as well as a PDF and video presentation on your product, various information about your company, and your team. The application process will take about 30 min for each challenge (dependent on whether or not you have all the information readily available).

For further information and to apply, please visit:
https://www.g4a.health

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...